Literature DB >> 20227262

Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.

R P Donahue1, J M Dorn, S Stranges, M Swanson, K Hovey, M Trevisan.   

Abstract

BACKGROUND AND AIMS: There is little epidemiological evidence regarding the association of impaired glucose metabolism with recurrent cardiovascular events. We therefore examined potential sex differences in the effect of impaired fasting glucose (IFG) on recurrent cardiovascular disease (CVD) in a community-based study of survivors of a first acute myocardial infarction (MI). METHODS AND
RESULTS: This report focuses on 1226 incident MI cases (28.4% women) discharged alive from area hospitals in the Western New York Acute MI Study (1996-2004). Deaths and underlying cause of death were determined via query of the National Death Index (Plus) Retrieval Program with follow-up through December 31, 2004. Outcomes reported included fatal or non-fatal coronary heart disease (CHD) or coronary revascularization surgery and total stroke. Traditional CHD risk factors and other explanatory variables were determined by clinical examination after the first acute event. Impaired fasting glucose was defined as fasting blood glucose between 100 and 125mg/dl. During a mean follow-up of 4.5 years, there were 91 recurrent events (26.1%) in women and 173 recurrent events (19.7%) in men. After multivariable adjustment, the hazard ratios for recurrent cardiovascular events were 1.96 (95% CI: 1.15-3.16) and 2.59 (1.56-4.30) in women with IFG and with diabetes, respectively, compared to normoglycemic women. Among men, neither IFG nor diabetes was independently related to risk of recurrence.
CONCLUSIONS: In this study, IFG was a strong risk factor for recurrent cardiovascular events only among women. These results suggest that increased cardiovascular risk in MI survivors begins at lower glucose levels in women than men.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227262      PMCID: PMC2888844          DOI: 10.1016/j.numecd.2009.11.012

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  29 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Intra- and interindividual variability of glucose tolerance in an elderly population.

Authors:  E J Feskens; C H Bowles; D Kromhout
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

3.  Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

Authors:  Mark O Goodarzi; Bruce M Psaty
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

4.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction.

Authors:  A Hamsten; G Walldius; G Dahlén; B Johansson; U De Faire
Journal:  Atherosclerosis       Date:  1986-02       Impact factor: 5.162

5.  Comparability of old and new World Health Organization criteria for definite myocardial infarction.

Authors:  R Beaglehole; A W Stewart; M Butler
Journal:  Int J Epidemiol       Date:  1987-09       Impact factor: 7.196

6.  Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart.

Authors:  J M Olefsky; G M Reaven
Journal:  Diabetes       Date:  1974-05       Impact factor: 9.461

7.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

Review 8.  Diabetes mellitus and macrovascular complications. An epidemiological perspective.

Authors:  R P Donahue; T J Orchard
Journal:  Diabetes Care       Date:  1992-09       Impact factor: 19.112

9.  Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey.

Authors:  J M Sprafka; G L Burke; A R Folsom; P G McGovern; L P Hahn
Journal:  Diabetes Care       Date:  1991-07       Impact factor: 19.112

10.  The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

Authors:  R D Abbott; R P Donahue; W B Kannel; P W Wilson
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

View more
  4 in total

Review 1.  Cardiovascular risk stratification and management in pre-diabetes.

Authors:  Kristine Færch; Dorte Vistisen; Nanna Borup Johansen; Marit Eika Jørgensen
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

2.  Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia.

Authors:  Chanchal Chandramouli; Melissa E Reichelt; Claire L Curl; Upasna Varma; Laura A Bienvenu; Parisa Koutsifeli; Antonia J A Raaijmakers; Miles J De Blasio; Cheng Xue Qin; Alicia J Jenkins; Rebecca H Ritchie; Kimberley M Mellor; Lea M D Delbridge
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

3.  Gender Differences in the Risk of Ischemic Heart Disease According to Healthcare Utilization and Medication Adherence among Newly Treated Korean Hypertensive Patients.

Authors:  Jiae Shin; Dongwoo Ham; Hee Young Paik; Sangah Shin; Hyojee Joung
Journal:  Int J Environ Res Public Health       Date:  2021-01-31       Impact factor: 3.390

4.  Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in A Chinese cohort study.

Authors:  Shuolin Wu; Yuzhi Shi; Chunxue Wang; Qian Jia; Ning Zhang; Xingquan Zhao; Gaifen Liu; Yilong Wang; Liping Liu; Yongjun Wang
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.